Willdan Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Willdan Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 29, 2017 | $64.16M | Mar 9, 2018 |
| FY2017 | Sep 29, 2017 | $69.01M | Mar 9, 2018 |
| FY2017 | Jun 30, 2017 | $71.83M | Mar 9, 2018 |
| FY2017 | Mar 31, 2017 | $68.35M | Mar 9, 2018 |
| FY2017 | Dec 30, 2016 | $57.43M | Mar 9, 2018 |
| FY2017 | Sep 30, 2016 | $58.66M | Mar 9, 2018 |
| FY2017 | Jul 1, 2016 | $58.94M | Mar 9, 2018 |
| FY2017 | Apr 1, 2016 | $33.92M | Mar 9, 2018 |
| FY2016 | Jan 1, 2016 | $31.52M | Mar 10, 2017 |
| FY2016 | Oct 2, 2015 | $33.51M | Mar 10, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $173.69M | Feb 27, 2026 |
| FY2025 | Oct 3, 2025 | $182.01M | Feb 27, 2026 |
| FY2025 | Jul 4, 2025 | $173.47M | Feb 27, 2026 |
| FY2025 | Apr 4, 2025 | $152.39M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $144.06M | Feb 27, 2026 |
| FY2025 | Sep 27, 2024 | $158.25M | Feb 27, 2026 |
| FY2025 | Jun 28, 2024 | $141.00M | Feb 27, 2026 |
| FY2025 | Mar 29, 2024 | $122.49M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $155.68M | Mar 7, 2025 |
| FY2024 | Sep 29, 2023 | $132.74M | Mar 7, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $255.68M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $202.78M | Feb 27, 2026 |
| FY2025 | Dec 29, 2023 | $179.77M | Feb 27, 2026 |
| FY2024 | Dec 30, 2022 | $143.58M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $135.87M | Mar 8, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $18.71M | Feb 27, 2026 |
| FY2025 | Oct 3, 2025 | $13.72M | Feb 27, 2026 |
| FY2025 | Jul 4, 2025 | $15.44M | Feb 27, 2026 |
| FY2025 | Apr 4, 2025 | $4.69M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $7.69M | Feb 27, 2026 |
| FY2025 | Sep 27, 2024 | $7.35M | Feb 27, 2026 |
| FY2025 | Jun 28, 2024 | $4.59M | Feb 27, 2026 |
| FY2025 | Mar 29, 2024 | $2.94M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $8.03M | Mar 7, 2025 |
| FY2024 | Sep 29, 2023 | $1.57M | Mar 7, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $10.43M | Feb 27, 2026 |
| FY2025 | Oct 3, 2025 | $14.86M | Feb 27, 2026 |
| FY2025 | Jul 4, 2025 | $11.82M | Feb 27, 2026 |
| FY2025 | Apr 4, 2025 | $7.04M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $10.87M | Feb 27, 2026 |
| FY2025 | Sep 27, 2024 | $8.67M | Feb 27, 2026 |
| FY2025 | Jun 28, 2024 | $6.45M | Feb 27, 2026 |
| FY2025 | Mar 29, 2024 | $5.36M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $11.75M | Mar 7, 2025 |
| FY2024 | Sep 29, 2023 | $3.84M | Mar 7, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $80.08M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $72.07M | Feb 27, 2026 |
| FY2025 | Dec 29, 2023 | $39.21M | Feb 27, 2026 |
| FY2024 | Dec 30, 2022 | $9.43M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $9.80M | Mar 8, 2024 |
| FY2022 | Jan 1, 2021 | $47.03M | Mar 10, 2023 |
| FY2021 | Dec 27, 2019 | $11.62M | Mar 25, 2022 |
| FY2020 | Dec 28, 2018 | $7.57M | Mar 17, 2021 |
| FY2019 | Dec 29, 2017 | $11.07M | Mar 6, 2020 |
| FY2018 | Dec 30, 2016 | $21.60M | Mar 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $9.39M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $8.41M | Feb 27, 2026 |
| FY2025 | Dec 29, 2023 | $9.93M | Feb 27, 2026 |
| FY2024 | Dec 30, 2022 | $9.60M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $8.50M | Mar 8, 2024 |
| FY2022 | Jan 1, 2021 | $5.08M | Mar 10, 2023 |
| FY2021 | Dec 27, 2019 | $6.64M | Mar 25, 2022 |
| FY2020 | Dec 28, 2018 | $2.11M | Mar 17, 2021 |
| FY2019 | Dec 29, 2017 | $2.18M | Mar 6, 2020 |
| FY2018 | Dec 30, 2016 | $1.66M | Mar 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $544.21M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $464.86M | Feb 27, 2026 |
| FY2025 | Dec 29, 2023 | $415.59M | Feb 27, 2026 |
| FY2024 | Dec 30, 2022 | $409.67M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $394.42M | Mar 8, 2024 |
| FY2022 | Jan 1, 2021 | $403.02M | Mar 10, 2023 |
| FY2021 | Dec 27, 2019 | $439.91M | Mar 25, 2022 |
| FY2020 | Dec 28, 2018 | $300.91M | Mar 17, 2021 |
| FY2019 | Dec 29, 2017 | $138.17M | Mar 6, 2020 |
| FY2018 | Dec 30, 2016 | $108.35M | Mar 8, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $239.36M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $230.52M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $215.74M | Mar 7, 2025 |
| FY2023 | Dec 30, 2022 | $228.17M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $215.20M | Mar 10, 2023 |
| FY2021 | Jan 1, 2021 | $233.86M | Mar 25, 2022 |
| FY2020 | Dec 27, 2019 | $272.64M | Mar 17, 2021 |
| FY2019 | Dec 28, 2018 | $156.62M | Mar 6, 2020 |
| FY2018 | Dec 29, 2017 | $67.52M | Mar 8, 2019 |
| FY2017 | Dec 30, 2016 | $58.43M | Mar 9, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $304.85M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $234.34M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $199.85M | Mar 7, 2025 |
| FY2023 | Dec 30, 2022 | $181.50M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $179.22M | Mar 10, 2023 |
| FY2021 | Jan 1, 2021 | $169.16M | Mar 25, 2022 |
| FY2021 | Dec 27, 2019 | $167.28M | Mar 25, 2022 |
| FY2021 | Dec 28, 2018 | $144.29M | Mar 25, 2022 |
| FY2020 | Dec 29, 2017 | $70.65M | Mar 17, 2021 |
| FY2019 | Dec 30, 2016 | $49.92M | Mar 6, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $179.53M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $140.99M | Feb 27, 2026 |
| FY2025 | Dec 29, 2023 | $131.14M | Feb 27, 2026 |
| FY2024 | Dec 30, 2022 | $130.12M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $130.12M | Mar 8, 2024 |
| FY2022 | Jan 1, 2021 | $130.12M | Mar 10, 2023 |
| FY2021 | Dec 27, 2019 | $127.65M | Mar 25, 2022 |
| FY2020 | Dec 28, 2018 | $97.75M | Mar 17, 2021 |
| FY2019 | Dec 29, 2017 | $38.18M | Mar 6, 2020 |
| FY2018 | Dec 30, 2016 | $21.95M | Mar 8, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $89.70M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $37.15M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $14.58M | Mar 7, 2025 |
| FY2023 | Dec 30, 2022 | $3.65M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $12.10M | Mar 10, 2023 |
| FY2021 | Jan 1, 2021 | $20.52M | Mar 25, 2022 |
| FY2020 | Dec 27, 2019 | $35.01M | Mar 17, 2021 |
| FY2019 | Dec 28, 2018 | $30.17M | Mar 6, 2020 |
| FY2018 | Dec 30, 2017 | $20.14M | Mar 8, 2019 |
| FY2019 | Dec 29, 2017 | $19.59M | Mar 6, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $65.92M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $74.16M | Feb 27, 2026 |
| FY2025 | Dec 29, 2023 | $23.40M | Feb 27, 2026 |
| FY2024 | Dec 30, 2022 | $8.81M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $11.22M | Mar 8, 2024 |
| FY2022 | Jan 1, 2021 | $28.41M | Mar 10, 2023 |
| FY2020 | Dec 27, 2019 | $5.45M | Mar 17, 2021 |
| FY2019 | Dec 28, 2018 | $15.26M | Mar 6, 2020 |
| FY2018 | Dec 29, 2017 | $14.42M | Mar 8, 2019 |
| FY2017 | Dec 30, 2016 | $22.67M | Mar 9, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $48.46M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | $89.49M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | $97.43M | Mar 7, 2025 |
| FY2023 | Dec 30, 2022 | $107.45M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $100.57M | Mar 10, 2023 |
| FY2021 | Jan 1, 2021 | $113.17M | Mar 25, 2022 |
| FY2020 | Dec 27, 2019 | $130.35M | Mar 17, 2021 |
| FY2019 | Dec 28, 2018 | $70.79M | Mar 6, 2020 |
| FY2012 | Dec 28, 2012 | $3.63M | Mar 26, 2013 |
| FY2012 | Dec 30, 2011 | $933.0K | Mar 26, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | 1 | Feb 27, 2026 |
| FY2025 | Oct 3, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Jul 4, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Apr 4, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 27, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 28, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Mar 29, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | 0 | Mar 7, 2025 |
| FY2024 | Sep 29, 2023 | 0 | Mar 7, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | 1 | Feb 27, 2026 |
| FY2025 | Oct 3, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Jul 4, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Apr 4, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 27, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 28, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Mar 29, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | 0 | Mar 7, 2025 |
| FY2024 | Sep 29, 2023 | 0 | Mar 7, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | 14.76M | Feb 27, 2026 |
| FY2025 | Dec 27, 2024 | 14.17M | Feb 27, 2026 |
| FY2024 | Dec 29, 2023 | 13.68M | Mar 7, 2025 |
| FY2023 | Dec 30, 2022 | 13.30M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | 12.80M | Mar 10, 2023 |
| FY2021 | Jan 1, 2021 | 12.16M | Mar 25, 2022 |
| FY2020 | Dec 27, 2019 | 11.50M | Mar 17, 2021 |
| FY2019 | Dec 28, 2018 | 10.97M | Mar 6, 2020 |
| FY2018 | Dec 29, 2017 | 8.80M | Mar 8, 2019 |
| FY2017 | Dec 30, 2016 | 8.35M | Mar 9, 2018 |